Literature DB >> 2302950

Prospective endoscopic study of stress erosions and ulcers in critically ill neurosurgical patients: current incidence and effect of acid-reducing prophylaxis.

P Reusser1, K Gyr, D Scheidegger, B Buchmann, M Buser, W Zimmerli.   

Abstract

We studied prospectively 40 critically ill neurosurgical patients who required prolonged mechanical ventilation to determine the current incidence of stress-related gastroduodenal erosions and ulcers, and to assess endoscopically the efficacy of acid-reducing prophylactic treatment. Nineteen patients were randomized to receive ranitidine plus antacids if necessary to maintain gastric pH at greater than or equal to 4. The remaining 21 patients were given no drug prophylaxis. Gastric pH was significantly (p less than .001) higher in the treated group: 78% of pH readings were at greater than or equal to 4 as compared to 32% in the control group. However, after five study days, incidence and severity of stress lesions were similar in the two groups: nine patients in each group had more than five erosions, one treated patient had a gastric ulcer, and one control patient had duodenal ulcerations. No patient experienced clinically relevant upper GI bleeding. The lack of severe stress bleeding and the low ulcer rate contrast with results from earlier reports on similar patient populations. Furthermore, drug prophylaxis had no detectable benefit, as assessed endoscopically. These findings suggest that routine stress lesion prophylaxis may not be necessary in critically ill patients with comparable risk factors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2302950     DOI: 10.1097/00003246-199003000-00004

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  16 in total

1.  Effect of sucralfate on aspirin induced mucosal injury and impaired haemostasis in humans.

Authors:  N Hudson; F E Murray; A T Cole; B Filipowicz; C J Hawkey
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

2.  Twenty-four-hour intragastric pH patterns in ICU patients on ranitidine.

Authors:  J G Moore; T P Clemmer; S Taylor; A L Bishop; S Maggio
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

3.  Regulatory effect of histamine on the barrier function of intestinal mucosal.

Authors:  Ligeng Duan; Xiaoli Chen; J W Alexander
Journal:  J Gastrointest Surg       Date:  2010-04-30       Impact factor: 3.452

4.  Implementation of a clinical practice guideline for stress ulcer prophylaxis increases appropriateness and decreases cost of care.

Authors:  S Pitimana-aree; D Forrest; G Brown; A Anis; X H Wang; P Dodek
Journal:  Intensive Care Med       Date:  1998-03       Impact factor: 17.440

Review 5.  Gastrointestinal prophylaxis in neurocritical care.

Authors:  Clemens M Schirmer; Joshua Kornbluth; Carl B Heilman; Anish Bhardwaj
Journal:  Neurocrit Care       Date:  2012-02       Impact factor: 3.210

6.  Human gastroduodenojejunal manometry.

Authors:  D L Wingate
Journal:  Dig Dis Sci       Date:  1994-02       Impact factor: 3.199

Review 7.  Stress Ulcer Prophylaxis in Neurocritical Care.

Authors:  Jeffrey F Barletta; Alicia J Mangram; Joseph F Sucher; Victor Zach
Journal:  Neurocrit Care       Date:  2018-12       Impact factor: 3.210

8.  Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials.

Authors:  A Messori; S Trippoli; M Vaiani; M Gorini; A Corrado
Journal:  BMJ       Date:  2000-11-04

Review 9.  Selective decontamination of the digestive tract: the mechanism of action is control of gut overgrowth.

Authors:  Luciano Silvestri; Miguel A de la Cal; Hendrick K F van Saene
Journal:  Intensive Care Med       Date:  2012-09-22       Impact factor: 17.440

Review 10.  Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients. A systematic review of randomised clinical trials with meta-analysis and trial sequential analysis.

Authors:  Mette Krag; Anders Perner; Jørn Wetterslev; Matt P Wise; Morten Hylander Møller
Journal:  Intensive Care Med       Date:  2013-10-19       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.